Results 231 to 240 of about 25,055,062 (242)

Selective cyclooxygenase-2 (COX-2) inhibitors and breast cancer risk

Breast, 2011
Paul D Terry, Chiranjeev Dash
exaly  

Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation

European Journal of Pharmacology, 1998
Derek W Gilroy, Derek A Willoughby, A Tomlinson   +2 more
exaly  

Investigations of new lead structures for the design of novel cyclooxygenase-2 inhibitors

European Journal of Medicinal Chemistry, 2002
Saïd Yous, Philippe Chavatte, Michel Luyckx   +2 more
exaly  

Acute Urinary Retention Associated With The Use Of Cyclooxygenase-2 Inhibitors

Journal of Urology, 2002
Gary J Faerber
exaly  

SAR and QSAR models of cyclooxygenase-1 (COX-1) inhibitors

SAR and QSAR in Environmental Research, 2018
Aixia Yan
exaly  

Cyclooxygenase inhibitors – current status and future prospects

European Journal of Medicinal Chemistry, 2001
Werner Kiefer, G Dannhardt, Gerd Dannhardt   +2 more
exaly  

4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)

Medicinal Research Reviews, 1999
Jaime L Masferrer, Carol M Koboldt, John J Talley   +2 more
exaly  

Cyclooxygenase-2 Inhibitors, Nonsteroidal Anti-inflammatory Drugs, and Cardiovascular Risk

Cardiology Clinics, 2008
Orly Vardeny, Scott Solomon
exaly  

Indole based cyclooxygenase inhibitors: Synthesis, biological evaluation, docking and NMR screening

European Journal of Medicinal Chemistry, 2012
Eduarda Fernandes, Luísa R Carvalho, Marisa Freitas   +2 more
exaly  

Cardiovascular Risk of Selective Cyclooxygenase-2 Inhibitors

Journal of Cardiovascular Pharmacology and Therapeutics, 2005
Jawahar L Mehta, Paulette Mehta
exaly